HOXA10 and central nervous system cancer: In addition, the expression of HOXA10 and HOXA13 increased in the WHO IV gliomas compared to the WHO II & III gliomas, and the mRNA expression of HOTTIP increased from WHO II gliomas to WHO IV gliomas.